PlainRecalls
FDA Drug Low Class III Terminated

Venlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet, a) 30-count bottle (NDC 636290-3324-2), b) 100-count bottle (NDC 63629-3324-6), Rx Only, Manufactured by Teva Pharmaceuticals USA, Inc. Packaged by Bryant Ranch.

Reported: May 11, 2016 Initiated: March 25, 2016 #D-0837-2016

Product Description

Venlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet, a) 30-count bottle (NDC 636290-3324-2), b) 100-count bottle (NDC 63629-3324-6), Rx Only, Manufactured by Teva Pharmaceuticals USA, Inc. Packaged by Bryant Ranch.

Reason for Recall

Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate release formulation.

Details

Recalling Firm
Bryant Ranch Prepack Inc.
Units Affected
21 bottles (910 extended release tablets)
Distribution
Nationwide
Location
Burbank, CA

Frequently Asked Questions

What product was recalled?
Venlafaxine 75 mg Tablet, Compare to Effexor 75 mg Tablet, a) 30-count bottle (NDC 636290-3324-2), b) 100-count bottle (NDC 63629-3324-6), Rx Only, Manufactured by Teva Pharmaceuticals USA, Inc. Packaged by Bryant Ranch.. Recalled by Bryant Ranch Prepack Inc.. Units affected: 21 bottles (910 extended release tablets).
Why was this product recalled?
Labeling: Label Mix-Up: Bryant Ranch received Tevas venlafaxine hydrochloride extended-release tablets for repackaging, but labeled it incorrectly as the immediate release formulation.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 11, 2016. Severity: Low. Recall number: D-0837-2016.